Modivcare Unveils Leadership Transitions Amid Strategic Evolution of Business Model

Modivcare Announces Executive Leadership Transitions Amid Strategic Business Model Evolution Modivcare Inc. (Nasdaq: MODV), a leading technology-enabled healthcare services company focused on delivering supportive care solutions that address social determinants of health, today announced the planned departures of two key…

Read MoreModivcare Unveils Leadership Transitions Amid Strategic Evolution of Business Model

TAE Life Sciences Partners with Ohio State University to Drive Innovation in Boron-Based Cancer Therapies

TAE Life Sciences and Ohio State Forge Landmark Partnership to Advance Boron-Based Precision Cancer Therapies In a significant leap forward for precision oncology, TAE Life Sciences (TLS), a pioneer in accelerator-based cancer treatment technologies, has announced a transformative collaboration with…

Read MoreTAE Life Sciences Partners with Ohio State University to Drive Innovation in Boron-Based Cancer Therapies

Emmy-Winning Series Unveils Trailer for Shelter Me: The Cancer Pioneers, Highlighting Breakthroughs in Cancer Treatment and Hope

Emmy-Winning Series Unveils Trailer for Shelter Me: The Cancer Pioneers, a Moving Documentary on Dogs Leading the Fight Against Cancer The Emmy Award-winning Shelter Me series has released the official trailer for its newest and most impactful installment yet: Shelter…

Read MoreEmmy-Winning Series Unveils Trailer for Shelter Me: The Cancer Pioneers, Highlighting Breakthroughs in Cancer Treatment and Hope

HAYA Therapeutics to Unveil RNA-Guided Genome Platform at ASGCT Meeting

HAYA Therapeutics to Present Breakthroughs in RNA-Guided Regulatory Genome Platform at 2025 ASGCT Annual Meeting HAYA Therapeutics, SA, a biotechnology company at the forefront of developing precision RNA-guided therapeutics that reprogram pathogenic cell states, announced today its participation at the…

Read MoreHAYA Therapeutics to Unveil RNA-Guided Genome Platform at ASGCT Meeting

Immunome Announces Inducement Grants in Accordance with Nasdaq Rule 5635(c)(4)

Immunome Grants Equity Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4) as Part of Talent Expansion Strategy Immunome, Inc. (Nasdaq: IMNM), a clinical-stage biotechnology company pioneering innovative cancer therapies with a focus on first-in-class and best-in-class antibody-based treatments, announced…

Read MoreImmunome Announces Inducement Grants in Accordance with Nasdaq Rule 5635(c)(4)

Astria Therapeutics Grants Inducement Awards Pursuant to Nasdaq Rule 5635(c)(4)

Astria Therapeutics Grants Stock Options to New Employees Under Nasdaq Listing Rule 5635(c)(4) Astria Therapeutics, Inc. (Nasdaq: ATXS), a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for allergic and immunologic diseases, has announced the granting of stock options to…

Read MoreAstria Therapeutics Grants Inducement Awards Pursuant to Nasdaq Rule 5635(c)(4)